ICER expanding conversation from drug pricing to fair drug access

ICER is aiming to promote consideration of market access for prescription drugs with a set of criteria for use by payers, patients and employers to see how well insurer coverage policies align with a set of standards for fair access.

Six months after publishing its first report on Barriers to Fair Access Assessment, on the coverage criteria used by health insurers to control access to drugs, ICER has expanded its list of formularies to include those for the Department of Veteran Affairs and the two largest state ACA exchange health plans...